Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 171 - 180 of 200 for wx. (0.11 seconds)

Foundation Medicine, a US company that has developed a...
WuXi PharmaTech’s Q2 results showed the company is...
OrbiMed Advisors will raise $300 million for a new...
WuXi PharmaTech, China’s largest CRO, reported that...
Eddingpharm in-licensed greater-China rights to a novel...
WuXi PharmaTech said one of its contract manufacturing...
3SBio acquired China rights for a novel renal failure...
WuXi PharmaTech signed an exclusive license to the Mayo...
Lorem Vascular of Australia will pay up to $531 million...
WuXi PharmaTech announced that its CMO subsidiary,...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here